Operational Plan Report

Implementing Mechanism Details

Mechanism ID: 13268	Mechanism Name: American Society of Clinical Pathology
Funding Agency: U.S. Department of Health and Human Services/Centers for Disease Control and Prevention	Procurement Type: Cooperative Agreement
Prime Partner Name: American Society of Clinical Pathology
Agreement Start Date: Redacted	Agreement End Date: Redacted
TBD: No	New Mechanism: N/A
Global Fund / Multilateral Engagement: N/A
G2G: N/A	Managing Agency: N/A

Total Funding: 425,000	Total Mechanism Pipeline: N/A
Funding Source	Funding Amount
GHP-State	425,000

Sub Partner Name(s)

(No data provided.)

Overview Narrative

The American Society for Clinical Pathology (ASCP) is a CDC central multi-country PEPFAR cooperative agreement partnered with CDC to improve laboratory training and implement laboratory quality improvement initiatives. In Ukraine, ASCP's goal is to strengthen the HIV laboratory system and overall laboratory system, especially in human capacity. In stakeholders’ meetings, ASCP developed a plan for 1) training courses for national/regional laboratory personnel in key clinical laboratory techniques and quality control; and 2) a process to improve pre-service curricula.

MOH approval of full implementation of the plan has been delayed due to restructuring of the MOH and AIDS control program. Recent steps by ASCP included review of two recent laboratory curricula from the Kiev laboratory pre-service training institute.

ASCP contributes to goals 2 and 3 of Ukraine’s Partnership Framework related to improved quality/ cost effectiveness of HIV services for MARPs; and strengthened national/local ability to achieve Ukraine’s AIDS Program objectives. These activities support the goals in the MOH strategy on counseling, testing and laboratory diagnosis of 2009.

ASCP’s cost efficiency includes coordination with and leverage of GF Rd 10 grant resources for lab strengthening and advocacy with the GOU to increase funding for laboratory strengthening. All ASCP activities are designed to increase national capacity and ownership. For example, training plans include a 'train-the-trainer' component to allow national staff to conduct future trainings.

Monitoring and evaluation activities for this activity will include tracking of trainees by the National Reference Laboratory to ensure that all appropriate staff and a cadre of trainers receive the required courses.

Global Fund / Programmatic Engagement Questions
1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? Yes

2. Is this partner also a Global Fund principal or sub-recipient? Neither

3. What activities does this partner undertake to support global fund implementation or governance?

Budget Code	Recipient(s) of Support	Approximate Budget	Brief Description of Activities
HLAB	MOH	275000	Current mechanism will increase the capacity of GoU to conduct lab activities under GF Rd 10.

Cross-Cutting Budget Attribution(s)

Human Resources for Health

80,952

TBD Details

(No data provided.)

Motor Vehicles Details

N/A

Key Issues

(No data provided.)

Budget Code Information

Mechanism ID: Mechanism Name: Prime Partner Name:	13268 American Society of Clinical Pathology American Society of Clinical Pathology
Strategic Area	Budget Code	Planned Amount	On Hold Amount
Governance and Systems	HLAB	425,000	0
Narrative:
ASCP FY12 funds will be used to continue the Curriculum development process in Clinical Chemistry/Hematology/CD4. This activity will take place at national and regional academies of postgraduate education which provide the preservice training for higher level laboratory workers (advanced degree equivalent). In addition, initial discussions are occurring in February 2012 with MOH and medical institutes that train laboratory technologist equivalent workers on curricula improvement . Funds will be used to support the HIV National Reference Laboratory and the Ukrainian Reference Center (UkRC) in the development and implementation of external quality assurance (EQA) programs for CD4. (The UkRC has been made responsible for initiating/coordinating EQA in Ukraine and began these operations in 2009 has recently begun EQA programs. EQA in HIV assays has been limited to small-scale EQA of HIV serology in 2010.) ASCP will also continue implementing laboratory best practices within the HIV laboratory network. This cooperation will be primarily at the central level - the NRL and the UkRC, which will develop national regulations. Further assistance will be provided for the implementation of these documents in the local laboratories (support training for local laboratory staff). ASCP will conduct an evaluation of additional changes within HIV laboratory services made possible/necessary by health care reform legislation being drafted in the Ukraine parliament. • PEPFAR II indicators: These indicators (no. of testing laboratories and number of accredited laboratories) provide limited information for programming laboratory support in Ukraine. Currently, the number of testing laboratories in the HIV laboratory system is sufficient; however, quantitative capacity in some assays needs to be augmented and the qualitative capacity, especially human, of all laboratories needs to be strengthened. All laboratories in the system are nationally accredited except for the HIV National Reference Laboratory (due to its lack of adequate physical facilities); however, numerous gaps exist in quality management. ASCP activities are addressing these gaps. • Coverage: Currently coverage with laboratory testing is adequate nationwide with the exception of prison populations. CDC is participating in planning for laboratory capacity augmentation under the GF Round 10 funding to cope with anticipated growth in needs and to extend coverage to prison populations; however, add’l laboratories are not planned. As additional capacity is developed, ASCP activities will include them into training and human resource development planning. • Training in management and quality assurance: these trainings are a major part of ASCP laboratory trainings and pre-service curricula. • All CDC-supported laboratory activities in Ukraine target enhancing the capacity of the MOH laboratory system.

Implementing Mechanism Details

Mechanism ID: 13435	Mechanism Name: MOH
Funding Agency: U.S. Department of Health and Human Services/Centers for Disease Control and Prevention	Procurement Type: Cooperative Agreement
Prime Partner Name: Ministry of Health- Swaziland
Agreement Start Date: Redacted	Agreement End Date: Redacted
TBD: No	New Mechanism: N/A
Global Fund / Multilateral Engagement: N/A
G2G: N/A	Managing Agency: N/A

Total Funding: 250,000	Total Mechanism Pipeline: N/A
Funding Source	Funding Amount
GHP-State	250,000

Sub Partner Name(s)

(No data provided.)

Overview Narrative

The goals of the MOH Capacity Building mechanism are to develop capacity in Strategic Information (SI), Laboratory Strengthening, and Blood Safety within the Ukrainian AIDS Center (UAC) and the regional AIDS center network. In 2009, a National M&E Unit (NMEU) was created in UAC to oversee HIV SI as part of the ‘Three Ones’. UAC is restructuring three lab units as a National HIV Reference Laboratory, to be located in a single facility. Both the NMEU and NHRL will need substantial technical assistance to develop strategic plans, policies, procedures, and staff capacity to assume their roles. The NHRL will need additional equipment and renovated facilities. The UAC recently became the first GOU GF Principal Recipient and needs extensive capacity development to fill the roles planned for the grant period. CDC support through this mechanism was included in GF grant planning to avoid overlap while providing for capacity development not covered by GF.

Obstacles to implementation include a lack of MOH experience with assistance as no previous grants had been implemented. The original MOH unit (State Committee on HIV/AIDS) slated to be the implementer was dissolved in GoU administrative reforms in 2011 and a new State Service on HIV/AIDS was established. After extensive intraGOU discussions, the State Service is taking steps with the Ministry of Economy to develop and approve administrative procedures to receive funds and conduct activities under this agreement.

The MOH project contributes to all goals of Ukraine’s Partnership Framework: directly to goals 2 (improved quality/cost effectiveness of HIV services for MARPs) and 3 (strengthened national/local ability to achieve national program objectives); and indirectly to goal 1 (reduction of HIV transmission among MARPs).

Global Fund / Programmatic Engagement Questions
1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? Yes

2. Is this partner also a Global Fund principal or sub-recipient? Neither

3. What activities does this partner undertake to support global fund implementation or governance?

Budget Code	Recipient(s) of Support	Approximate Budget	Brief Description of Activities
HLAB	MOH	100000	Current mechanism will strenthen MOH capacities relevant to implementation of Lab activities under GF.
HVSI	MOH	100000	MOH is responsible for implementation of the National AIDS program and coordinates GF-related activities. Current mechanism will strenthen MOH capacities relevant to implementation of SI activities under GF.

Cross-Cutting Budget Attribution(s)

Human Resources for Health

150,000